Edition:
United Kingdom

Shanghai Pharmaceuticals Holding Co Ltd (2607.HK)

2607.HK on Hong Kong Stock

21.00HKD
20 Apr 2018
Change (% chg)

HK$0.00 (+0.00%)
Prev Close
HK$21.00
Open
HK$21.00
Day's High
HK$21.00
Day's Low
HK$21.00
Volume
2,440,000
Avg. Vol
6,791,668
52-wk High
HK$24.25
52-wk Low
HK$18.20

Chart for

About

Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascula... (more)

Overall

Beta: 0.83
Market Cap(Mil.): HK$68,781.16
Shares Outstanding(Mil.): 2,688.91
Dividend: --
Yield (%): --

Financials

  2607.HK Industry Sector
P/E (TTM): 13.41 20.98 40.93
EPS (TTM): 1.48 -- --
ROI: 11.01 11.72 62.12
ROE: 10.70 13.91 73.69

BRIEF-Shanghai Pharmaceuticals Holding to pay cash dividend of 3.8 yuan (pre-tax) for every 10 shares

* Says it plans to pay a cash dividend of 3.8 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017

26 Mar 2018

BRIEF-Shanghai Pharmaceuticals' 2017 Net Profit Up, To Issue Bonds, Debt Financing Instruments

March 23 Shanghai Pharmaceuticals Holding Co Ltd :

23 Mar 2018

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says co's Shanghai-based wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for therapeutic biological products

05 Mar 2018

Shanghai Pharmaceuticals plans $400 mln share sale to fund production

HONG KONG, Jan 19 Shanghai Pharmaceuticals Holding Co Ltd said on Friday it planned to sell HK$3.13 billion ($400 million) worth of new shares to fund the development of its manufacturing and distribution businesses.

19 Jan 2018

BRIEF-Shanghai Pharmaceuticals Holding To Place 153.2 Mln New H Shares At HK$20.43 Per H Share​

* ‍TO PLACE 153.2 MILLION NEW H SHARES AT HK$20.43 PER H SHARE​

19 Jan 2018

BRIEF-Shanghai Pharmaceuticals Holding units receive GMP certificate

* Says Changzhou-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, for its products including acyclovir, ganciclovir and production line

10 Jan 2018

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its unit received goods manufacture practice (GMP) certificate from Shandong Food and Drug Administration, for its products including mixture, oral liquid, drops and bulk drug

05 Jan 2018

BRIEF-Shanghai Pharmaceuticals Holding Announces ‍CSRC's Approval On Issuance Of New Shares

* ANNOUNCES ‍CSRC'S APPROVAL ON ISSUANCE OF NEW 153.2 MILLION H SHARES AT VALUE OF RMB1 PER SHARE​ Source text for Eikon: Further company coverage:

29 Dec 2017

BRIEF-Shanghai Pharmaceuticals Gets Regulatory Approval To Issue Up To 153.2 Mln H-Shares

* SAYS IT GETS SECURITIES REGULATOR'S APPROVAL TO ISSUE UP TO 153.2 MILLION H-SHARES Source text in Chinese: http://bit.ly/2C81gx7 Further company coverage: (Reporting by Hong Kong newsroom)

29 Dec 2017

Earnings vs. Estimates